Former NFL quarterback Tom Brady has ventured into a remarkable new chapter of family life after revealing that his dog Junie is a clone of his late pet, Lua, who passed away in December 2023. Speaking to People, Brady explained that Colossal Biosciences, a biotech firm in which he holds an investment, utilized blood collected from Lua before her death to create Junie.
Brady expressed his deep love for animals, stating, “They mean the world to me and my family.” He detailed his experience with Colossal, noting that he worked alongside them to employ their non-invasive cloning technology, which involved a straightforward blood draw from Lua before she passed away.
This announcement comes on the heels of Colossal’s recent acquisition of Viagen Pets and Equine, another biotech company. Brady shared his excitement about how this collaboration between Colossal and Viagen can not only provide families with an opportunity to reunite with cloned pets but also contribute to the preservation of endangered species.
This innovative approach to pet cloning exemplifies how technology can help mitigate the emotional impact of losing a beloved animal while simultaneously addressing conservation efforts for endangered species. Brady’s journey highlights the evolving intersections of biotechnology and personal experiences, offering a hopeful perspective for pet owners facing similar heartaches.